- Open Access
EDITORIAL: Eating disorders in diabetes: Discussion on issues relevant to type 1 diabetes and an overview of the Journal’s special issue
Journal of Eating Disorders volume 7, Article number: 27 (2019)
Research suggests that women with Type 1 diabetes mellitus (T1DM) have close to 2.5 times the risk for developing an eating disorder compared to women without T1DM . Women with T1DM can present with the full range of eating disordered symptoms however, the majority of research is focused only on those involving insulin restriction as a weight control behavior. It is unclear why girls and women with T1DM have increased rates of disordered eating behaviors and diagnosed eating disorders, but T1DM is strongly associated with a number of common eating disorder risk factors. For example, people with diabetes have twice the risk of clinically significant depression than those without diabetes . Women and girls with T1DM also often have a higher BMI than their peers without diabetes . Far less is known about Type 2 Diabetes (T2DM) and eating disorders  but management can be similarly challenging when it is comorbid with an eating disorder.
Other aspects of diabetes treatment may also increase the risk of eating disorders. The treatment itself involves paying close attention to refined carbohydrates and to food portions which can parallel the rigid thinking about food, weight, and body image reported by women with eating disorders who do not have diabetes . Such treatment recommendations can lead to feelings of deprivation, resentment and shame, and to binge eating. Studies have found that disturbed eating behaviors in T1DM are strongly predicted by higher Body Mass Index (BMI), higher shape and weight concerns, lower self-esteem, and depressed mood. Positive feelings about appearance, the absence of depression, and a lower BMI may be protective factors [6,7,8,9]. Higher diabetes-related family conflict also appears to be a risk factor . Notably, adolescence is a time of increased risk for both eating disorders and for worsening of glycemic control. The latter could reflect metabolic changes during this time, and as well it is the period when responsibility for insulin administration transitions from the parent(s) to the child.
Women with T1DM and eating disorders have A1c values approximately 2 or more percentage points higher than similarly aged women with T1DM without eating disorders. (The A1c is a laboratory test that estimates the average blood glucose values over a three-month period.) Patients who restrict insulin as a purging behaviour have higher rates of hospital and emergency room visits, higher rates of medical complications, and more negative attitudes toward T1DM than women who do not report insulin restriction [11,12,13]. Endorsing just insulin restriction alone was shown to increase mortality risk 3-fold over an 11-year period . Even lower threshold disordered eating behaviors are strongly associated with significant medical and psychological consequences . Although current treatment encourages a goal A1c of 7% or below, this target can seem unattainable and lead to disengagement from self-management of T1DM. Alternatively, diabetes treatment goals can also encourage perfectionism and lead to frustration, because blood glucose cannot be kept in range at all times.
Diabetes specialists report feeling frustrated by the dearth of specialized treatment programs for eating disorders in people with T1DM . T1DM patients with eating disorders are more likely to drop out of treatment and also show worse outcomes with conventional outpatient treatment for eating disorders [17, 18]. Longer stays in residential treatment are reportedly associated with better outcomes, perhaps highlighting greater complexity and need in this population . Taken together, this information underscores the need for effective treatments for eating disorders in T1DM. Current treatment guidelines are helpful but limited as they are based upon clinical expertise rather than rigorous research [20,21,22].
This special issue of the Journal of Eating Disorders addresses vital gaps in the research literature. At the time of this Editorial the following papers were published. Abbott and colleagues conducted a systematic review of Binge Eating Disorder (BED) and Night Eating Syndrome (NES) in adults with Type 2 diabetes mellitus (T2DM) . They found that BED and NES are common among adults with T2DM, and that BED is associated with higher BMI in these patients. Moskovich and colleagues performed assessments of affect using a real-time telephone-based survey system among patients with T1DM . They found negative affect and distress over their diabetes increased risk for objective binge eating at the upcoming meal. Studies by Wisting’s group evaluated the Diabetes Eating Problems Survey-Revised (DEPS-R)  and employed the survey, along with other measures, to address similarities and differences in eating disorder behaviors, depression, and anxiety experienced by males and females with T1DM . Including males is a much needed advance. They found that worse glucose control, reflected by a higher A1c, was correlated with a higher DEPS-R score. Finally, different screening methods produce different results regarding rates of eating disorders in this population. The paper by Keane and colleagues examines this issue by using the EDE-Q, considered the gold standard screening questionnaire, and report lower rates than previously reported . This finding adds to the debate over whether validated general screenings, modified screenings, or T1DM specific screening tools are the best approach when trying to identify eating disorders in the population with T1DM.
In summary, this Special Issue highlights much needed next steps to improve knowledge and clinical care for this high risk population with complex needs. For further reading we suggest the 2017 text by Goebel-Fabbri  also reviewed in this Special Issue . We look forward to an improved understanding of the management of diabetes concurrent with an eating disorder.
Availability of data and materials
Body Mass Index
Type 1 Diabetes
Jones JM, Lawson ML, Daneman D, Olmsted MP, Rodin G. Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study. Br Med J. 2000;320:1563–6.
De Groot MAR, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63:619–30.
Domargard A, Sarnblad S, Kroon M, Karlsson I, Skeppner G, Aman J. Increased prevalence of overweight in adolescent girls with type 1 diabetes mellitus. Acta Paediatr. 1999;88:1223–8.
Abbott S, Dindol N, Tahrani AA, Piya MK. Binge eating disorder and night eating syndrome in adults with type 2 diabetes: a systematic review. J Eat Disord 2018;6:36.
Daneman D, Olmsted M, Rydall A, Maharaj S, Rodin G. Eating disorders in young women with type 1 diabetes: prevalence, problems and prevention. Horm Res. 1988;50:79–86.
Olmsted MP, Colton PA, Daneman D, Rydall AC, Rodin GM. Prediction of the onset of disturbed eating behavior in adolescent girls with type 1 diabetes. Diabetes Care. 2008;31:1978–82.
Markowitz JT, Lowe MR, Volkening LK, Laffel LMB. Self-reported history of overweight and its relationship to disordered eating in adolescent girls with type 1 diabetes. Diabet Med. 2009;26:1165–71.
Goebel-Fabbri AE, Anderson B, Fikkan J, Franko DL, Pearson K, Weinger K. Improvement and emergence of insulin restriction in women with type 1 diabetes. Diabetes Care. 2011;34:545–50.
Colton PA, Olmsted MP, Daneman D, Rydall AC, Rodin GM. Natural history and predictors of disturbed eating behaviour in girls with type 1 diabetes. Diabet Med. 2007;24:424–9.
Wilson CE, Smith EL, Coker SE, Hobbis IC, Acerini CL. Testing an integrated model of eating disorder in paediatric type 1 diabetes mellitus. Pediatr Diabetes. 2015;16(7):521–8.
Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF. Insulin omission in women with IDDM. Diabetes Care. 1994;17:1178–85.
Rydall AC, Rodin GM, Olmsted MP, Devenyi RG, Daneman D. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med. 1997;336:1849–54.
Bryden KS, Neil A, Mayou RA, Peveler RC, Fairburn CG, Dunger DB. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care. 1999;22:1956–60.
Goebel-Fabbri AE, Fikkan J, Franko DL, Pearson K, Anderson BJ, Weinger K. Insulin restriction and associated morbidity and mortality in women with type 1 diabetes. Diabetes Care. 2008;31:415–9.
Verrotti A, Catino M, De Luca FA, Morgese G, Chiarelli F. Eating disorders in adolescents with type 1 diabetes mellitus. Acta Diabetol. 1999;36:21–5.
Tierney S, Deaton C, Whitehead J. Caring for people with type 1 diabetes mellitus engaging in disturbed eating or weight control: a qualitative study of practitioners’ attitudes and practices. J Clin Nurs. 2009;18(3):384–90.
Colton PA, Olmsted MP, Daneman D, Farquhar JC, Wong H, Muskat S, et al. Eating disorders in girls and women with type 1 diabetes: a longitudinal study of prevalence, onset, remission, and recurrence. Diabetes Care. 2015;38(7):1212–7.
Custal N, Arcelus J, Aguera Z, Bove FI, Wales J, Granero R, et al. Treatment outcome of patients with comorbid type 1 diabetes and eating disorders. BMC Psychiatry. 2014;14:140.
Dickens YL, Haynos AF, Nunnemaker S, Platka-Bird L, Dolores J. Multidisciplinary residential treatment of type 1 diabetes mellitus and co-occurring eating disorders. Eat Disord. 2015;23(2):134–43.
Criego A, Crow S, Goebel-Fabbri AE, Kendall D, Parkin C. Eating disorders and diabetes: screening and detection. Diabetes Spectrum. 2009;22(3):143–6.
Goebel-Fabbri AE, Polonsky W, Uplinger N, Gerkin S, Mangham D, Moxness R, et al. Outpatient management of eating disorders in type 1 diabetes. Diabetes Spectrum. 2009;22(3):147–52.
Bermudez O, Gallivan H, Jahraus J, Lesser J, Meier M, Parkin C. Inpatient management of disorders in type 1 diabetes. Diabetes Spectrum. 2009;22(3):153–8.
Moskovich AA, Dmitrieva NO, Babyak MA, Smith PJ, Honeycutt LK, Mooney JT, Merwin RM. Real-time predictors and consequences of binge eating among adults with type 1 diabetes. J Eat Disord. 2019;7(1):7.
Wisting L, Wonderlich J, Skrivarhaug J, Dahl-Jørgensen K, Rø Ø. Psychometric properties and factor structure of the diabetes eating problem survey – revised (DEPS-R) among adult males and females with type 1 diabetes. J Eat Disord. 2019;7:2.
Wisting L, Skrivarhaug J, Dahl-Jørgensen K, Rø Ø. Prevalence of disturbed eating behavior and associated symptoms of anxiety and depression among adult males and females with type 1 diabetes. J Eat Disord. 2018;6:28.
Keane S, Clarke M, Murphy M, McGrath D, Smith D, Farrelly N, MacHale S. Disordered eating behaviour in young adults with type 1 diabetes mellitus. J Eat Disord. 2018;6:9.
Goebel-Fabbri A. Prevention and recovery from eating disorders in type 1 diabetes: injecting Hope. NY. ISBN: Routledge; 2017. isbn:978-1-138-89061-9
Hay P. Book Review: Prevention and Recovery from Eating Disorders in Type 1 Diabetes: Injecting Hope Journal of Eating Disorders 2019;7:3.
Ethics approval and consent to participate
Consent for publication
Professor Hay receives/has received sessional fees and lecture fees from the Australian Medical Council, Therapeutic Guidelines publication, and New South Wales Institute of Psychiatry and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, and Blackwell Scientific Publications, Biomed Central and PlosMedicine and she has received research grants from the NHMRC and ARC. She is Chair of the National Eating Disorders Collaboration Steering Committee in Australia (2019-) and Member of the ICD-11 Working Group for Eating Disorders (2012-) and was Chair Clinical Practice Guidelines Project Working Group (Eating Disorders) of RANZCP (2012–2015). She has prepared a report under contract and conducted education for Psychiatrists funded by Shire Pharmaceuticals (2017–2018). All views in this paper are her own. Stephen Touyz has received royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, and Blackwell Scientific Publications, and Biomed Central and he has received research grants from the NHMRC and ARC. He is consultant to Shire Pharmaceuticals. All views in this paper are his own. Ann Goebel-Fabbri is author of a book cited in this Editorial and receives royalties from Routledge Press. Paul Copeland served on an Advisory Board for AstraZenica.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.